Intranasal Dexmedetomidine Premedication in Children
NCT02250703 is a phase 3 interventional trial sponsored by University of Mississippi Medical Center. As of 18 Nov 2026, it is completed. It studies Dexmedetomidine and Midazolam in Preoperative Sedation. The registry lists an enrollment of 75 participants at 1 site in 1 country. The registry lists a start date of 30 Sept 2014 and a primary completion date of 30 Sept 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02250703 |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | University of Mississippi Medical Center |
| Enrollment | 75 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Preoperative Sedation |
| Drugs | Dexmedetomidine and Midazolam |
| Start | 30 Sept 2014 |
| Primary completion | 30 Sept 2016 |
| Study completion | 30 Sept 2016 |
| Last update posted | 7 Jul 2017 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Madhankumar Sathyamoorthy, MBBS, MS
University of Mississippi Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children's of Mississippi/university of Mississipi Medical Center
Jackson
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT02250703
Each answer restates registry values shown on this page.
What is NCT02250703?
NCT02250703 is a phase 3 interventional trial sponsored by University of Mississippi Medical Center. It studies Dexmedetomidine and Midazolam in Preoperative Sedation.
Who leads NCT02250703?
The registry names Madhankumar Sathyamoorthy, MBBS, MS (principal investigator, University of Mississippi Medical Center) as the overall official.
Where does NCT02250703 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT02250703 study?
The registered drug and biological interventions are Dexmedetomidine and Midazolam.
When did NCT02250703 end?
The registry lists a primary completion date of 30 Sept 2016 and a study completion date of 30 Sept 2016. The sponsor last updated the record on 7 Jul 2017.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.